biomedicina slovenica

re="Angiology" : 44-143

44. Šurlan M; Klančar J; Kuhelj D; Salapura V; Ključevšek T; Stankovič M; Berden P; Kunst T
    Interventional radiology in haemodialysis fistuale and grafts
    2004 ►
45. Šikovec A
    Endoscopic ligation of perforators in chronic venous insufficiency
    2004 ►
46. Mušič M; Cankar K; Finderle Ž
    The correlation between cold perception and skin microcirculatory response to local cooling
    2004 ►
47. Miloševič Z
    Carotid angioplasty and stenting with different cerebral protection devices
    2004 ►
48. Melik Ž; Cankar K
    The effect of diazepam on gender differences in cutaneous LD flux response to local cooling
    2004 ►
49. Lenasi H; Štrucl M
    Effect of regular endurance training on cutaneous postocclusive reactive hyperaemia
    2004 ►
50. Kuhelj D; Šurlan M; Salapura V; Berden P; Klančar J; Ključevšek T; Kunst T; Popovič P; Stankovič M; Glušič M
    Multidetector CTA of peripheral arteries - a new method for pathology detection
    2004 ►
51. Kozak M
    Diagnostic assessment if chronic limb ischemia - basis for therapeutic interventions
    2004 ►
52. Kocijančič I; Miloševič Z
    Acute carotid stent thrombosis: successful treatment with second carotid stent placement
    2004 ►
53. Klokočovnik T
    Treatment of abdominal aortic aneurysms by minilaparotomy
    2004 ►
54. Kecelj-Leskovec N; Planinšek-Ručigaj T; Godić A
    Compression theories about long-stretch snd short-strecth bandages in practice
    2004 ►
55. Horvat-Ledinek A
    Cerebral sinus thrombosis
    2004 ►
56. Flis V; Tetičkovič E
    Three dimensional ultrasound of atherosclerotic plaques in internal carotid artery: comparison of GSM values between symptomatic and asymptomatic pati
    2004 ►
57. Fras Z
    Comprehensive assessment of cardiovascular risk
    2004 ►
58. Eržen B; Šebeštjen M; Šabovič M; Keber I; Poredoš P
    Inflammation parameters in young post-myocardial patients with high or low coronary risk
    2004 ►
59. Eržen B; Šebeštjen M; Šabovič M; Keber I; Poredoš P
    Comparison of endothelial dysfunction in young postmyocardial patients with high or low coronary risk
    2004 ►
60. Černe A; Noč M
    Safety and efficacy of Preclose suturing device after percutaneous coronary procedure
    2004 ►
61. Cankar K; Finderle Ž; Štrucl M
    The effect of calcium-blockers on cutaneous postocclusive reactive hyperaemia
    2004 ►
62. Berden P; Vrtovec M
    Role of CT angiography in diagnosis of traumatic aortic injury
    2004 ►
63. Starc V
    Effects of hypoxemia and metabolic activity on the density of the perfused capillaries in the muscle tissue
    2004 ►
64. Potočnik N; Arnol M; Marc O; Starc V
    Changes in the finger artery compliance in man during mental stress
    2004 ►
65. Blinc A
    Secondary prevention in peripheral arterial disease - what is the evidence?
    2004 ►
66. Legan Mateja; Vraspir-Porenta Olga; Keše Darja; Zorc-Pleskovič Rusa; Zorc Mateja
    Histopathologic signs for the inflammatory role of Chlamydia pneumoniae in the high-grade atherosclerotic coronary artery wall
    2004 ►
67. Tetičkovič E; Menih M
    Role of 3D ultrasonography in evaluating carotid disease
    2004 ►
68. Šeruga T; Markovič I
    Endosacular coil embolisation of unruptured intracranial artery aneurysms in the posterior cerebral circulation with GDC detachable coils
    2004 ►
69. Lobnik A; Kanič V
    First experience with iloprost in patients with coronary heart disease unsuitable for revascularization
    2004 ►
70. Flis V; Miksić K; Stirn B
    Carotid endarterectomy - results from the Maribor general/teaching hospital
    2004 ►
71. Šebeštjen M; Žegura B; Videčnik V; Keber I
    Determinators of endothelial dysfunction and carotid intima media thickness in combined hyperlipidemia
    2004 ►
72. Petrovič Daniel; Bregar Dejan; Gužič-Salobir Barbara; Škof Erik; Špan Matjaž; Terzić Rifet; Globočnik-Petrovič Mojca; Keber Irena; Letonja Mitja; Zorc Marjeta; Podbregar M; Peterlin Borut
    Sex difference in the effect of ACE-DD genotype on the risk of premature myocardial infarction
    2004 ►
73. Pavlovič M; Matela J; Miksić K; Flis V
    Peripheral congenital arteriovenous fistulae: observe, operate, or obturate?
    1999 ►
74. Pavlovič Milan; Flis Vojko; Miksić Kazimir
    Does the Taylor patch improve longe-term results of PTFE grafts?
    1999 ►
75. Matela J; Pavlovič M; Miksić K; Flis V
    Peripheral congenital arteriovenous fistulae: observe, operate, or obturate?
    1999 ►
76. Zorc Marjeta; Zorc-Pleskovič Ruda; Vraspir-Porenta Olga; Legan Mateja; Petrovič Daniel
    Apoptosis and histopathologic changes in diffuse coronary atherosclerosis
    2003 ►
77. Prešern-Štrukelj Metka; Poredoš Pavel
    The influence of electrostimulation on the circulation of the remaining leg in patients with one-sided amputation
    2002 ►
78. Salobir Barbara; Šabovič Mišo; Peternel Polona; Stegnar Mojca
    Fibrinolytic parameters and lipoprotein(a) in young women with myocardial infarction
    2002 ►
79. Lokar L; Urlep-Šalinović V; Zagradišnik B; Kokalj-Vokač N
    Correlation beetwen ProC Global assay and coagulation inhibitor assays
    2001 ►
80. Samama Meyer Michel; Desnoyers Pierre; Gerotziafas Grigoris T
    Low molecular weight heparins: a comparative review of pharmacodynamic, clinical pharmacology
    2001 ►
81. Samama MM; Kher A
    Anticoagulation: the old and new
    2001 ►
82. Scholz T; Krause S; Finkelberg L; Loesche W
    Detection of small platelet aggregates and their inhibition by glycoprotein IIb/IIIa antagonists in a laser aggregometer
    2001 ►
83. Niessner A; Kaun C; Christiansen G; Pedersen AS; Simon S; Zorn G; Georgopoulos A; Graninger W; Huber K; Wojta J
    Outer membrane protein 11 (OMP 11) and OMP 15 of Chlamydia pneumoniae induce the chemokine interleukin-8 (IL-8) and the pro-inflammatory cytokine IL-6 in human endothelial cells in vitro
    2001 ►
84. Weiss T; Macfelda K; Kaun C; Zorn G; Kapeller B; Springer C; Bialy J; Losert UM; Breuss JM; Binder BR
    Inflammatory cytokines and growth factors regulate plasminogen activator inhibitor-1 (PAI-1) in human adult cardiac myocytes (HACM)
    2001 ►
85. Miles LA; Green M; Gong A; Jardi M; Felez J
    Monoclonal antibodies detect receptor-induced binding sites (RIBS) in plasminogen induced by its interaction with cells
    2001 ►
86. Barrowcliffe TW; Jardi M; Cancelas JA; Rabaneda M; Fabregas P; Felez J
    Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid
    2001 ►
87. Barrowcliffe TW; Rabaneda M; Gray E; Felez J
    Procoagulant activity of activated endothelial cells - the importance of negatively charged phospholipids
    2001 ►
88. Speidl WS; Graf S; Nikfardjam M; Niessner A; Zorn G; Wojta J; Huber K
    High sensitivity C-reactive protein predicts risk for further coronary events in stable patients with premature coronary artery disease
    2001 ►
89. Hiltunen L; Paunio M; Kaaja R; Vahtera E; Krusius T; Rasi V
    A prospective nested case control study of thromboembolic complications of pregnancy
    2001 ►
90. Kuismanen K; Salonvaara M; Mononen T; Riikonen P
    Treatment of a newborn with neonatal purpura fulminans in a family with hereditary type II protein C deficiency
    2001 ►
91. Niessner A; Hornykewycz S; Joerg M; Zorn G; Graf S; Binder BR; Huber K
    Increased risk of restenosis after successful percutaneous transluminal coronary angioplasty in patients with permanently elevated anticardiolipin antibodies
    2001 ►
92. Michiels JJ; Kasbergen HAA; Trienekens PH
    Evidence for safe exclusion of deep vein thrombosis (DVT- by a rapid ELISA D-dimer test in 434 consecutive outpatients with suspected DVT
    2001 ►
93. Michiels JJ; Posthuma W; Ponjee GAE; Stef E; Quint WG; van Doorn LJ
    DNA typing for thrombophilia-related factor V leiden and prothrombing G20210A mutations by multiplex PCR and reverse hybridisation LiPA in 473 thrombosis patients
    2001 ►
94. Furlan M
    New strategies in diagnosis and treatment of thrombocitic thrombocytopenic purpura
    2001 ►
95. Vermylen J
    Heparin-induced thrombocytopenia
    2001 ►
96. Prandoni P
    The optimal treatment of venous thrombosis
    2001 ►
97. Vermylen J
    Platelet glycoprotein receptor antagonists
    2001 ►
98. Felez J
    Cell surface associated fibrinolysis
    2001 ►
99. Blinc A
    Transport of fibrinolytic agents as a rate-limiting step in fibrinolysis and thrombolysis
    2001 ►
100. Palareti G
     Laboratory and therapeutic quality control of anticoagulant treatment: an update
     2001 ►
101. Collen D; Lijnen HR
     Recent developments in thrombolytic therapy
     2001 ►
102. Lijnen HR
     Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems
     2001 ►
103. Lowe GDO
     Lipoprotein(a) and cardiovascaular disease
     2001 ►
104. Lowe GDO
     Fibrinogen, fibrin D-dimer and cardiovascular disease
     2001 ►
105. Juhan-Vague I; Alessi MC; Morange PE
     Hypofibrinolysis and increased PAI-I are linked to atherothrombosis via insulin resistance and obesity
     2001 ►
106. Iacoviello L; Donati MB
     Gene-environment interactions: the example of coagulation factors
     2001 ►
107. Castoldi E; Bernardi F
     Factor V markers for the detection of genetic components of APC resistance in venous thrombosis
     2001 ►
108. de Gaetano G; Rotondo S
     Mediterranean diet and cardiovascular disease
     2001 ►
109. Wiman B
     Fibrinolytic factors in connection with cardiovascular disease
     2001 ►
110. Pabinger-Fascing I
     Thrombophilia - a multigene defect
     2001 ►
111. Bertina R
     Identification of molecular risk markers for thrombosis
     2001 ►
112. Schved JF; Giansily M
     Tissue factor and tissue factor pathway inhibitor: from fundamental to clinic
     2001 ►
113. Binder BR
     Arterial thrombosis. Pathomechanism, prediction and therapy
     2001 ►
114. Geiger M
     Protein C inhibitor
     2001 ►
115. Perrier A
     D-dimer testing in suspected venous thromboembolism
     2001 ►
116. Ten Cate H
     Markers of blood coagulation activation
     2001 ►
117. Gaffney PJ
     Fibrin degradation products. A review of structures found in vitro and in vivo
     2001 ►
118. Galli M
     Antiphospholipid antibodies: predictive value of laboratory tests
     2001 ►
119. Kluft C
     Standardization of fibrinolysis methods
     2001 ►
120. Bazzoni G; Martinez-Estrada OM; Dejana E
     Molecular architecture of interendothelial junctions
     2001 ►
121. Levy-Toledano S
     Platelet signal transduction pathways: could we organize them into a "hierarchy"
     2001 ►
122. Poredoš P
     Endothelial dysfunction in the pathogenesis of atherosclerosis
     2001 ►
123. Poredoš P
     Endothelial dysfunction - what does this mean and how to measure it?
     2001 ►
124. Poredoš P
     Diagnostic assessment of arterial circulatory disturbances as a basis for therapeutic decisions in critical limb ischaemia
     2001 ►
125. Žemva Aleš; Žemva Žarka
     Ventricular ectopic activity, left ventricular mass, hyperinsulinemia, and intracellular magnesium in normotensive patients with obesity
     2000 ►
126. Šabovič Mišo; Bonač Barbara
     An unusual case of cortical blindness associated with aortography: a case report
     2000 ►
127. Petrovič Danijel; Zorc Marjeta; Kanič Vojko; Peterlin Borut
     Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction
     2001 ►
128. Videčnik V; Peternel P; Keber D
     Blood flow velocity measurment by Doppler ultrasound in carotid arteries in pacients with central retinal vessels occlusions
     1985 ►
129. Salomon MI; Lamovec J; Tchertkoff V
     Renal lesions in scleroderma
     1978 ►
130. Poredoš Pavel
     Regarding "Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction": in response reply to Dr. Milionis et al
     1999 ►
131. Poredoš P; Videčnik V
     Factors affecting the initial and long term efficacy of intraarterial thrombolysis
     1999 ►
132. Poredoš P; Orehek M; Tratnik E
     Smoking is associated with dose related increase of intima-media thickness and endothelial dysfunction
     1999 ►
133. Poredoš Pavel; Žižek Bogomir
     Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease
     1996 ►
134. Pust Borut; Šurlan Miloš
     Pre-PTCA detection of chronic but reversible postischemic myocardial dysfunction by nicardipine
     1998 ►
135. Koželj M; Pavčnik D; Šurlan M
     Asymmetric hypertrophic cardiomyopathy diagnosed by echocardiography and magnetic resonance imaging: case reports
     1996 ►
136. Koželj M; Angelski R; Pavčnik D
     Lipomatous hypertrophy of the interatrial septum: diagnosis by echocardiography and magnetic resonance imaging. A case report
     1995 ►
137. Videčnik V; Peternel P; Keber D
     Blood velocity measurement by Doppler ultrasound in carotid arteries in patients with central retinal vessels occlusions
     1986 ►
138. Kozak M
     How reliable is the clinical diagnosis of acute leg deep venous thrombosis?
     1992 ►
139. Poredoš P; Likar B
     Transcutaneous oxygen tension in different stages of peripheral arterial disease (PAOD)
     1992 ►
140. Poredoš P; Videčnik V; Šurlan M; Miklavčič L
     Local treatment of pripheral arterial occlusion disease with streptokinase and plasminogen
     1986 ►
141. Poredoš P; Keber D; Videčnik V
     Late results of local thrombolytic treatment of peripheral arterial occlusions
     1989 ►
142. Poredoš P; Stegnar M; Gačnik A
     Basal and post-stimulation fibrinolytic activity in patients with peripheral arterial atherosclerotic disease
     1990 ►
143. Poredoš P; Videčnik V; Keber D
     Therapeutic success of local thrombolytic treatment of peripheral arterial occlusion depending on systemic fibrinolytic effect
     1986 ►

   1 44

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics